Please login to the form below

Not currently logged in
Email:
Password:

MSD appoints new UK head

Mike Nally moves from Swedish division
MSD MIke Nally

Merck Sharp and Dohme (MSD) has announced that Mike Nally is to take on the role of managing director of the company's operations in the UK and Ireland.

Nally will take over the role on January 1, 2014, moving from his current position as managing director of MSD in Sweden.

He replaces Deepak Khanna who has been appointed to a new senior VP role at MSD where he will lead the company's oncology efforts across Europe.

As previously announced, Khanna will also step down from his role as president of the Association of the British Pharmaceutical Industry (ABPI) to be replaced by Pfizer's Jonathan Emms.

Commenting on Nally's work in Sweden, MSD said that “he has led the company to become a more customer centric organisation in a dynamic, payer-based environment”.

10th December 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics